SEC Form 4 · accession 0001645627-18-000014
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Mar 2, 2018
Accepted (ET)
Mar 13, 2018 · 11:47 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2018 | P | 1,000 | $0.041 | A | 24,838,189 | D | |
| common Stock | Mar 2, 2018 | P | 1,000 | $0.0393 | A | 24,849,189 | D | |
| Common Stock | Mar 5, 2018 | P | 1,000 | $0.039 | A | 24,850,189 | D | |
| Common Stock | Mar 5, 2018 | P | 1,000 | $0.04 | A | 24,851,189 | D | |
| Common Stock | Mar 5, 2018 | P | 1,000 | $0.0396 | A | 24,852,189 | D | |
| Common Stock | Mar 5, 2018 | P | 1,000 | $0.0399 | A | 24,853,189 | D | |
| Common Stock | Mar 6, 2018 | P | 1,000 | $0.041 | A | 24,854,189 | D | |
| Common Stock | Mar 6, 2018 | P | 1,000 | $0.041 | A | 24,855,189 | D | |
| Common Stock | Mar 6, 2018 | P | 1,000 | $0.041 | A | 24,856,189 | D | |
| Common Stock | Mar 7, 2018 | P | 1,000 | $0.0399 | A | 24,857,189 | D | |
| Common Stock | Mar 7, 2018 | P | 1,000 | $0.0399 | A | 24,858,189 | D | |
| Common Stock | Mar 7, 2018 | P | 1,000 | $0.0399 | A | 24,859,189 | D | |
| Common Stock | Mar 9, 2018 | P | 1,000 | $0.0411 | A | 24,860,189 | D | |
| Common Stock | Mar 9, 2018 | P | 1,000 | $0.0428 | A | 24,861,189 | D |
Table II — derivative securities
No Table II lines on this filing.